Reports - In-vitro Lung Model Market
Biotechnology and Life SciencesIn-vitro Lung Model Market
In-vitro Lung Model Market Trends, Growth & Innovations (2025–2035) by Type (2D Cell Models, 3D Cell Models) by Application (Drug Screening, Toxicology, Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global In-vitro Lung Model Market - Segment Analysis
1. Overview
2. Global In-vitro Lung Model Market, 2021 - 2035 (USD Million)
3. Global In-vitro Lung Model Market - by Type
3.1. By 2D Cell Models
3.2. By 3D Cell Models
4. Global In-vitro Lung Model Market - by Application
4.1. By Drug Screening
4.2. By Toxicology
4.3. By Others
5. Global In-vitro Lung Model Market - by region
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Latin America
5.5. Middle East & Africa
6. Market comparative analysis
Chapter 4 North America In-vitro Lung Model Market - Segment Analysis
1. Overview
2. North America In-vitro Lung Model Market, 2021 - 2035 (USD Million)
3. North America In-vitro Lung Model Market - by Type
3.1. By 2D Cell Models
3.2. By 3D Cell Models
4. North America In-vitro Lung Model Market - by Application
4.1. By Drug Screening
4.2. By Toxicology
4.3. By Others
Chapter 5 Europe In-vitro Lung Model Market - Segment Analysis
1. Overview
2. Europe In-vitro Lung Model Market, 2021 - 2035 (USD Million)
3. Europe In-vitro Lung Model Market - by Type
3.1. By 2D Cell Models
3.2. By 3D Cell Models
4. Europe In-vitro Lung Model Market - by Application
4.1. By Drug Screening
4.2. By Toxicology
4.3. By Others
Chapter 6 Asia Pacific In-vitro Lung Model Market - Segment Analysis
1. Overview
2. Asia Pacific In-vitro Lung Model Market, 2021 - 2035 (USD Million)
3. Asia Pacific In-vitro Lung Model Market - by Type
3.1. By 2D Cell Models
3.2. By 3D Cell Models
4. Asia Pacific In-vitro Lung Model Market - by Application
4.1. By Drug Screening
4.2. By Toxicology
4.3. By Others
Chapter 7 Latin America In-vitro Lung Model Market - Segment Analysis
1. Overview
2. Latin America In-vitro Lung Model Market, 2021 - 2035 (USD Million)
3. Latin America In-vitro Lung Model Market - by Type
3.1. By 2D Cell Models
3.2. By 3D Cell Models
4. Latin America In-vitro Lung Model Market - by Application
4.1. By Drug Screening
4.2. By Toxicology
4.3. By Others
Chapter 8 Middle East & Africa In-vitro Lung Model Market - Segment Analysis
1. Overview
2. Middle East & Africa In-vitro Lung Model Market, 2021 - 2035 (USD Million)
3. Middle East & Africa In-vitro Lung Model Market - by Type
3.1. By 2D Cell Models
3.2. By 3D Cell Models
4. Middle East & Africa In-vitro Lung Model Market - by Application
4.1. By Drug Screening
4.2. By Toxicology
4.3. By Others
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Epithelix (Switzerland)
2. MatTek Corporation (US)
3. Lonza (Switzerland)
4. ATCC (US)
5. InSphero (Switzerland)
6. Emulate (US)
7. AlveoliX (Switzerland)
8. Oncotheis (Switzerland)
9. Insphero (Switzerland)
10. TissUse (Switzerland)
11. Mimetas (Netherlands)
12. and CN Bio Innovations (UK).
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By